SNCA and multiple system atrophy: In addition, a recent pilot study showed that the levels of phosphorylated α-synuclein at serine 129 (pS-α-syn) were significantly higher in MSA patients than in healthy controls, suggesting that phosphorylated α-synuclein in red blood cells is a potential diagnostic biomarker for MSA [96].